RMED, HOOK, JZXN, ACRS, OPRA, CVAC Stock Prices Fall Intraday

By Amit Chowdhry ● Jun 8, 2021
  • The stock prices of RMED, HOOK, JZXN, ACRS, OPRA, and CVAC have fallen noticeably today. These are the details.

The stock prices of RMED, HOOK, JZXN, ACRS, OPRA, and CVAC SI have fallen noticeably today. Here is more information:

RA Medical Systems Inc (NYSEAMERICAN: RMED) – Over 16% Drop

The stock price of RA Medical Systems Inc (NYSEAMERICAN: RMED) fell by over 16% during intraday trading. Investors were likely collecting profits as the stock price increased by over 95% between Friday June 4 and yesterday afternoon.

Hookipa Pharma Inc (NASDAQ: HOOK) – Over 15% Drop

The stock price of Hookipa Pharma Inc (NASDAQ: HOOK) fell by over 15% during intraday trading. Investors are responding negatively to the company’s Phase 1 data from its ongoing Phase 1/2 study (NCT04180215) of HB-200 for the treatment of advanced Human Papillomavirus 16-positive (HPV16+) cancers.

Jiuzi Holdings Inc (NASDAQ: JZXN) – Over 15% Drop

The stock price of Jiuzi Holdings Inc (NASDAQ: JZXN) fell by over 15% during intraday trading. There is no company-specific news driving the stock price drop.

Aclaris Therapeutics Inc (NASDAQ: ACRS) – Over 14% Drop

The stock price of Aclaris Therapeutics Inc (NASDAQ: ACRS) fell by over 14%. Investors are responding negatively to the company’s preliminary topline results from its first in human Phase 2a, multicenter, randomized, double-blind, vehicle-controlled, parallel-group clinical trial to evaluate the efficacy, safety, tolerability and pharmacokinetics of ATI-1777, an investigational topical “soft” JAK 1/3 inhibitor, in 50 subjects with moderate to severe atopic dermatitis (AD) (ATI-1777-AD-201).

Opera Ltd (NASDAQ: OPRA) – Over 13% Drop

The stock price of Opera Ltd (NASDAQ: OPRA) fell by over 13% during intraday trading. There is no company-specific news driving the stock price down. 

CureVac BV (NASDAQ: CVAC) – Over 13% Drop

The stock price of CureVac BV (NASDAQ: CVAC) fell by over 13% during intraday trading. Investors are responding negatively to a report by Reuters that the European Medicines Agency (EMA) does not expect to make a decision on the approval of CureVac’s COVID-19 vaccine before August.

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.